HALEOSLABS vs VALIANTLAB: Stock Comparison

Haleos Labs Limited vs Valiant Laboratories Limited

Live data: 22 July 2026, 3:04 PM IST • Source: NSE and company filings

Haleos Labs Limited is the larger company by market capitalisation. Haleos Labs Limited shows a higher ROE, a higher dividend yield and a higher ROCE, while Valiant Laboratories Limited shows a lower P/E and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Haleos Labs Limited and Valiant Laboratories Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, HALEOSLABS is more favourable on 6 of 13 scored metrics and VALIANTLAB on 5These counts are context-free and are not an overall rating.

Key Differences

Market Cap
HALEOSLABS is the larger company
₹484 Cr vs ₹332 Cr
P/E Ratio
VALIANTLAB has a lower P/E
-101.88x vs 27.94x
P/B Ratio
VALIANTLAB has a lower P/B
1.07x vs 2.27x
EPS
HALEOSLABS has higher earnings per share
₹57.3 vs ₹-0.05
Dividend Yield
HALEOSLABS has a higher dividend yield
0.1% vs 0%
Qtr Sales Growth
VALIANTLAB has stronger quarterly sales growth
148% vs -15.7%
Qtr Profit Growth
VALIANTLAB has stronger quarterly profit growth
457% vs -85.2%
ROE
HALEOSLABS has a higher ROE
8.44% vs -1.05%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricHALEOSLABSVALIANTLAB
SectorHealthcare
IndustryPharmaceuticals

Price

MetricHALEOSLABSVALIANTLAB
Live Price₹1,522.4₹81.65
Day Change-3.09%2.55%
Volume28187,489
52-Week High₹1,774₹100.98
52-Week Low₹1,181₹49.51
Distance from 52W High-14.18%-19.14%

Valuation

MetricHALEOSLABSVALIANTLAB
Market Cap₹484 Cr₹332 Cr
P/E Ratio27.94x-101.88x
P/B Ratio2.27x1.07x
EPS₹57.3₹-0.05
Book Value₹706₹50.08
Dividend Yield0.1%0%

Growth

MetricHALEOSLABSVALIANTLAB
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth-15.7%148%
Qtr Profit Growth-85.2%457%

Profitability & Leverage

MetricHALEOSLABSVALIANTLAB
ROE8.44%-1.05%
ROCE9.91%-0.95%
Net Margin5.33%-1.38%
Operating Margin13.4%1.12%
Debt to Equity0.52x0.14x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricHALEOSLABSVALIANTLAB
Promoter Holding72.11%74.94%
FII Holding0%0% 0.2 pp
DII Holding0.31% 0.01 pp0%
Public Holding27.58% 0.02 pp25.06% 0.2 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Haleos Labs Limited and Valiant Laboratories Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.